Actividad Investigadora
Contratos Sara Borrell
Datos básicos
- Código:
- CD15/00095
- Dotación:
- 80.598,00 €
- Año Inicial:
- 2016
- Año final:
- 2018
Objetivos del proyecto
La contratación, en centros del ámbito del SNS, de Doctores recién titulados en el campo de las ciencias y tecnologías de la salud, para perfeccionar su formación. La incorporación a los centros beneficiarios se formalizará por medio de contratos de trabajo de tres años de duración, suscritos entre el investigador y el centro contratante, al amparo de lo establecido en la legislación aplicable. Los contratos de trabajo tendrán una dotación de 26.866,00 euros anuales en concepto de retribución bruta salarial, distribuidos preferentemente en 14 pagas, que el ISCIII financiará en su totalidad. Las cuotas empresariales a la Seguridad Social y resto de gastos de contratación correrán a cargo de la entidad beneficiaria.
Documentos
- No hay documentos
Participantes
Financiadores
Resultados del Proyecto
A Genome-Wide Association Study Identifies rs116199914 As an Intergenic Variant Associated with Carotid Intima-Media Thickness in Spanish Patients with Rheumatoid Arthritis
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 2018
A Genome-Wide Association Study Suggests the HLA Class II Region As the Major Susceptibility Locus for IgA Vasculitis
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 2017
Anti-IL-6 Therapy Modulates Leptin in Patients with Rheumatoid Arthritis
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 2018
Anti-IL-6 therapy modulates leptin in patients with rheumatoid arthritis
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2018-eular.5614. 2018
Assessment of Serum Calprotectin and Osteoprotegerin Levels in a Cohort of Spanish Patients with Axial Spondyloarthritis
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 2016
Association of HLA-DRB1*0301 with Antisynthetase Syndrome in Spanish Patients
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 2018
Association of Osteonectin, Osteopontin and Osteocalcin with Inflammation and Cardiovascular Risk in Patients with Axial Spondyloarthritis
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 2017
Beneficial effect of anti-IL-6 blockade on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6998. 2018
Beneficial Effect of Anti-IL-6 Blockade on Insulin Resistance and Insulin Sensitivity in Patients with Rheumatoid Arthritis
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 2017
Decreased expression of PTPN22 gene in patients with rheumatoid arthritis carrying the risk allele of PTPN22 RS2488457 polymorphism
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5839. 2017
DIFFERENTIAL EXPRESSION OF OPG/RANKL/TRAIL SYSTEM IN RHEUMATOID ARTHRITIS
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2016-eular.2702. 2016
Effect of anti-IL-6 therapy on serum levels of metabolic syndrome-related biomarkers in rheumatoid arthritis patients
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6829. 2018
GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2019-eular.1942. 2019
IL-17A GENE IMPLICATION IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS
Genre, F; (...); González-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2016-eular.2690. 2016
Implication of osteonectin on cardiovascular risk in axial spondyloarthritis: a serological and genetic study
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2018-eular.5186. 2018
Omentin-1: Potential Biomarker of Cardiovascular Risk in Axial Spondyloarthritis? a Serological and Genetic Study
Genre, F; (...); Gonzalez-Gay, MA
Meeting Abstract. 2018
Protective Role of the Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Rs2495477 Polymorphism in Patients with Rheumatoid Arthritis
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 2018
PROTECTIVE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) RS2495477 POLYMORPHISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SUBCLINICAL ATHEROSCLEROSIS
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2019-eular.2383. 2019
Protein Tyrosine Phosphatase Non-Receptor 22 / C-Src Tyrosine Kinase Complex Down-Regulated in Patients with Rheumatoid Arthritis
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Meeting Abstract. 2017
ROLE OF PCR, GCKR, HNF1A, LEPR, ASCL1 AND NLRP3 IN ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Lopez-Mejias, R; (...); Gonzalez-Gay, MA
Meeting Abstract. 10.1136/annrheumdis-2016-eular.2654. 2016